Allogene Therapeutics Inc (ALLO) support and resistance · rev $22.0K
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
This page maps Allogene Therapeutics Inc (ALLO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
ALLO currently screens at market cap $258.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALLO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALLO quote page for the session range and the stock page for the full model.
Not investment advice.